Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ironwood Pharmaceuticals (IRWD) Other Gross PP&E Adjustments (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Other Gross PP&E Adjustments for 16 consecutive years, with -$3.6 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 52.62% to -$3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.6 million through Dec 2025, up 52.62% year-over-year, with the annual reading at -$3.6 million for FY2025, 52.62% up from the prior year.
  • Other Gross PP&E Adjustments hit -$3.6 million in Q4 2025 for Ironwood Pharmaceuticals, up from -$9.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$3.6 million in Q4 2025 to a low of -$17.3 million in Q2 2021.
  • Historically, Other Gross PP&E Adjustments has averaged -$12.5 million across 5 years, with a median of -$12.8 million in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: rose 1.9% in 2023 and later surged 52.62% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at -$15.0 million in 2021, then increased by 29.11% to -$10.6 million in 2022, then rose by 1.9% to -$10.4 million in 2023, then rose by 26.44% to -$7.7 million in 2024, then soared by 52.62% to -$3.6 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for IRWD at -$3.6 million in Q4 2025, -$9.8 million in Q3 2025, and -$10.2 million in Q2 2025.